Association of the TP53 rs1042522 C>G polymorphism and hepatoblastoma risk in Chinese children
Tianyou Yang, Wen Yang, Jiahao Li, Jiliang Yang, Tianbao Tan, Jing Pan, Chaosu Hu, Jiao Zhang, Yijuan Xin, Suhong Li, Huimin Xia, Jing He, Yan Zou · Journal of Cancer · 2019
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2019
Abstract
The TP53 gene encodes an important class of cell cycle and tumor-suppressing factors that play critical roles in maintaining genomic stability.The TP53 Arg72Pro (rs1042522 C>G) polymorphism has been reported to be associated with the risk of several types of adult cancers; however, its risk for pediatric cancers remains unclear.Here, we analyzed the association of the TP53 gene rs1042522 C>G polymorphism with hepatoblastoma (HB) susceptibility in a hospital-based study among Chinese children.A total of 213 HB patients and 958 healthy controls were enrolled in the study.Genotypes were determined by a TaqMan assay, and the strength of the association was assessed by the odds ratios and 95% confidence intervals generated from logistic regression models, adjusted for age, gender, and clinical stage.No significant association between the TP53 rs1042522 C>G polymorphism and HB susceptibility was detected in the main analysis or in stratification analyses of age, gender, and clinical stages.Overall, the TP53 gene rs1042522 C>G polymorphism is not associated with HB susceptibility in the Chinese population, other polymorphisms alone or in combination should be investigated to further clarify HB susceptibility.
Open the resolved locator · 10.7150/jca.33063
Metadata licence: OpenAlex metadata (CC0)